STAT4基因变异增加高加索慢性乙型肝炎患者肝纤维化风险
在高加索慢性乙型肝炎患者中,STAT4 rs7574865基因型与肝脏炎症(OR 1.42)和晚期纤维化(OR 1.83)独立相关;风险等位基因频率低于健康对照,GG风险携带者肝脏、外周血单核细胞和NK细胞中STAT4表达降低,NK细胞经IL-12/IL-18刺激后STAT4磷酸化受损且干扰素-γ分泌减少。
要点
- STAT4 rs7574865与高加索慢性乙肝患者肝脏炎症和晚期纤维化风险独立相关。
- 风险等位基因频率在慢性乙肝患者中显著低于健康对照。
- GG风险携带者STAT4表达降低,NK细胞STAT4磷酸化及干扰素-γ分泌受损。
核心结论
- 高加索人群对HBV持续感染、肝脏炎症和纤维化的遗传易感性与STAT4 rs7574865变异相关。
- 通过STAT4磷酸化依赖的干扰素-γ产生对NK细胞功能的下游影响可能介导这些效应。
研究设计与样本
- 对1085名受试者(830例慢性乙型肝炎患者和255名健康对照)进行STAT4 rs7574865基因分型。
- 检查肝脏、外周血单核细胞和NK细胞中STAT4表达、STAT4磷酸化及干扰素-γ分泌与STAT4遗传变异的关系。
主要发现
- STAT4 rs7574865基因型与肝脏炎症独立相关(OR 1.42,95%CI 1.07-2.06,P=0.02)。
- STAT4 rs7574865基因型与晚期纤维化独立相关(OR 1.83,95%CI 1.19-2.83,P=0.006)。
- rs7574865次要等位基因频率在慢性乙肝患者中显著低于健康对照。
- rs7574865 GG风险携带者肝脏、外周血单核细胞和NK细胞中STAT4表达水平较低。
- 风险基因型患者NK细胞经IL-12/IL-18刺激后STAT4磷酸化受损,干扰素-γ分泌减少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Host genetic modifiers of the natural history of chronic hepatitis B (CHB) remain poorly understood. Recently, a genome-wide association study (GWAS)-identified polymorphism in the STAT4 gene that contributes to the risk for hepatocellular carcinoma (HCC) was shown to be associated with the full spectrum of hepatitis B virus (HBV) outcomes in Asian patients. However, the functional mechanisms for this effect are unknown and the role of the variant in modulating HBV disease in Caucasians has not been investigated. AIMS: To determine whether STAT4 genetic variation is associated with liver injury in Caucasian patients with CHB and to investigate potential mechanisms mediating this effect. METHODS: STAT4 rs7574865 was genotyped in 1085 subjects (830 with CHB and 255 healthy controls). STAT4 expression in liver, PBMCs and NK cells, STAT4 phosphorylation and secretion of interferon-gamma (IFN-γ) according to STAT4 genetic variation was examined. RESULTS: STAT4 rs7574865 genotype was independently associated with hepatic inflammation (OR: 1.42, 95% CI: 1.07-2.06, P = 0.02) and advanced fibrosis (OR: 1.83, 95% CI: 1.19-2.83, P = 0.006). The minor allele frequency of rs7574865 was significantly lower than that in healthy controls. rs7574865 GG risk carriers expressed lower levels of STAT4 in liver, PBMCs and in NK cells, while NK cells from patients with the risk genotype had impaired STAT4 phosphorylation following stimulation with IL-12/IL-18 and a reduction in secretion of IFN-γ. CONCLUSION: Genetic susceptibility to HBV persistence, hepatic inflammation and fibrosis in Caucasians associates with STAT4 rs7574865 variant. Downstream effects on NK cell function through STAT4 phosphorylation-dependent IFN-γ production likely contribute to these effects.
引用
- El Sharkawy R, Thabet K, Lampertico P, et al. A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Aliment Pharmacol Ther. 2018. PMID: 29963713. doi:10.1111/apt.14866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。